Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin. | ||||
| Egyptian Journal of Medical Research | ||||
| Article 9, Volume 1, Issue 1, January 2020, Page 107-121 PDF (564.37 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejmr.2020.89076 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Mansour Hassan Ahmad Hassan1; Mohamed Osman2; Waleed El-Nabawy3; Alzahraa Yasseen Sayed* 1 | ||||
| 1Ophthalmology department, Faculty of Medicine, Beni-Suef University, Egypt | ||||
| 2Ophthalmology department, Faculty of Medicine, Beni-Suef University, Egypt. | ||||
| 3Internal medicine department, Faculty of Medicine, Beni-Suef University, Egypt | ||||
| Abstract | ||||
| Background: Chronic Hepatitis C is common problem worldwide treated by combination of interferon alpha and ribavirin. Retinopathy is one of the side effects of interferon therapy. Aim: determine the frequency and risk factors of retinopathy in patients with chronic hepatitis C treated by interferon and ribavirin combination therapy in Egypt. Methods and Results: Total 100 patients were enrolled among which, 16 (16%) developed retinopathy in the form of cotton wool spots and 14(14%) developed atypical complications. Conclusion: Retinopathy may occur in patients with chronic hepatitis C receiving interferon alpha and ribavirin. | ||||
| Keywords | ||||
| Retinopathy; Interferon; ribavirin; chronic hepatitis C | ||||
|
Statistics Article View: 249 PDF Download: 336 |
||||
